The audit committee is comprised of Helena Wennerström (chairman) and Niels Mengel. The audit committee’s role is mainly to monitor Ascelia Pharma’s financial position, to monitor the effectiveness of the Ascelia’s internal control, internal audit and risk management, to be informed about the audit of the annual report and consolidated financial statements, and to review and monitor the auditor’s impartiality and independence. The audit committee shall also assist the nomination committee in proposals for decisions on the election and remuneration of the auditor.